Esperion Therapeutics, Inc. (ESPR)
2.72
-0.05
(-1.81%)
USD |
NASDAQ |
Mar 06, 16:00
2.725
0.00 (0.00%)
After-Hours: 20:00
Esperion Therapeutics SG&A Expense (TTM) : 161.28M for Sept. 30, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Harrow, Inc. | 109.60M |
| Catalyst Pharmaceuticals, Inc. | 171.18M |
| Nektar Therapeutics | 74.62M |
| Rigel Pharmaceuticals, Inc. | 85.91M |
| AnaptysBio, Inc. | 50.74M |